Search

Search Results
Results 8111 - 8120 of 8126 for Skin Cancer
  • Duodopa
    Drug - 23 Apr 2020
    Consumer Medicine Information (CMI) about Duodopa intended for persons living in Australia.
  • Sodium Bicarbonate
    Drug - 7 Apr 2020
    Consumer Medicine Information (CMI) about Sodium Bicarbonate intended for persons living in Australia.
  • Baraclude
    Drug - 1 Apr 2020
    Consumer Medicine Information (CMI) about Baraclude (Entecavir) intended for persons living in Australia.
  • Triasyn
    Drug - 20 Dec 2019
    Consumer Medicine Information (CMI) about Triasyn (Ramipril and felodipine e-pril fell-odd-ip-een)) intended for persons living in Australia.
  • Thymoglobuline
    Drug - 27 Aug 2019
    Consumer Medicine Information (CMI) about Thymoglobuline (Rabbit anti-human thymocyte immunoglobulin) intended for persons living in Australia.
  • Cefepime Alphapharm
    Drug - 29 Jul 2019
    Consumer Medicine Information (CMI) about Cefepime Alphapharm (cefepime hydrochloride) intended for persons living in Australia.
  • Hexaxim
    Drug - 9 Apr 2019
    Consumer Medicine Information (CMI) about Hexaxim (Diphtheria, tetanus, pertussis , hepatitis B , poliomyelitis and Haemophilus influenzae type b conjugate vaccine) intended for...
  • Test document
    Drug - 17 Jan 2019
    Consumer Medicine Information (CMI) about Test document (darbepoetin alfa) intended for persons living in Australia.
  • Ramipril Winthrop
    Drug - 27 Sep 2017
    Consumer Medicine Information (CMI) about Ramipril Winthrop (Ramipril) intended for persons living in Australia.
  • Tritace
    Drug - 27 Sep 2017
    Consumer Medicine Information (CMI) about Tritace (Ramipril e-pril)) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback